Tong YA - Search Results

1

Oncogene- transformed NIH 3T3 cells display radiation resistance levels indicative of a signal transduction pathway leading to the radiation-resistant phenotype.

Pirollo KF, Tong YA, Villegas Z, Chen Y, Chang EH. Pirollo KF, et al. Among authors: tong ya. Radiat Res. 1993 Aug;135(2):234-43. Radiat Res. 1993. PMID: 8367595

2

Several mutant p53 proteins detected in cancer-prone families with Li-Fraumeni syndrome exhibit transdominant effects on the biochemical properties of the wild-type p53.

Srivastava S, Wang S, Tong YA, Pirollo K, Chang EH. Srivastava S, et al. Among authors: tong ya. Oncogene. 1993 Sep;8(9):2449-56. Oncogene. 1993. PMID: 8361758

3

Dominant negative effect of a germ-line mutant p53: a step fostering tumorigenesis.

Srivastava S, Wang S, Tong YA, Hao ZM, Chang EH. Srivastava S, et al. Among authors: tong ya. Cancer Res. 1993 Oct 1;53(19):4452-5. Cancer Res. 1993. PMID: 8402611

4

Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas.

Huang Y, Meltzer SJ, Yin J, Tong Y, Chang EH, Srivastava S, McDaniel T, Boynton RF, Zou ZQ. Huang Y, et al. Cancer Res. 1993 Apr 15;53(8):1889-94. Cancer Res. 1993. PMID: 8467510

5

The status of the p53 gene in human papilloma virus positive or negative cervical carcinoma cell lines.

Srivastava S, Tong YA, Devadas K, Zou ZQ, Chen Y, Pirollo KF, Chang EH. Srivastava S, et al. Among authors: tong ya. Carcinogenesis. 1992 Jul;13(7):1273-5. doi: 10.1093/carcin/13.7.1273. Carcinogenesis. 1992. PMID: 1322252

6

Detection of both mutant and wild-type p53 protein in normal skin fibroblasts and demonstration of a shared 'second hit' on p53 in diverse tumors from a cancer-prone family with Li-Fraumeni syndrome.

Srivastava S, Tong YA, Devadas K, Zou ZQ, Sykes VW, Chen Y, Blattner WA, Pirollo K, Chang EH. Srivastava S, et al. Among authors: tong ya. Oncogene. 1992 May;7(5):987-91. Oncogene. 1992. PMID: 1373881

7

An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein.

Doyle LA, Ross DD, Ordonez JV, Yang W, Gao Y, Tong Y, Belani CP, Gutheil JC. Doyle LA, et al. Br J Cancer. 1995 Sep;72(3):535-42. doi: 10.1038/bjc.1995.370. Br J Cancer. 1995. PMID: 7669558 Free PMC article.

8

Synergistic reversal of multidrug-resistance phenotype in acute myeloid leukemia cells by cyclosporin A and cremophor EL.

Ross DD, Wooten PJ, Tong Y, Cornblatt B, Levy C, Sridhara R, Lee EJ, Schiffer CA. Ross DD, et al. Blood. 1994 Mar 1;83(5):1337-47. Blood. 1994. PMID: 8118035 Free article.

9

Recombinant adenovirus vector expressing wild-type p53 is a potent inhibitor of prostate cancer cell proliferation.

Srivastava S, Katayose D, Tong YA, Craig CR, McLeod DG, Moul JW, Cowan KH, Seth P. Srivastava S, et al. Among authors: tong ya. Urology. 1995 Dec;46(6):843-8. doi: 10.1016/S0090-4295(99)80355-0. Urology. 1995. PMID: 7502427

10

Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers.

Huang Y, Boynton RF, Blount PL, Silverstein RJ, Yin J, Tong Y, McDaniel TK, Newkirk C, Resau JH, Sridhara R, Reid BJ, Meltzer SJ. Huang Y, et al. Cancer Res. 1992 Dec 1;52(23):6525-30. Cancer Res. 1992. PMID: 1423299

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters